CervoMed (CRVO) Enterprise Value (2022 - 2025)
CervoMed (CRVO) has disclosed Enterprise Value for 9 consecutive years, with -$20.9 million as the latest value for Q4 2025.
- Quarterly Enterprise Value rose 46.39% to -$20.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$20.9 million through Dec 2025, up 46.39% year-over-year, with the annual reading at -$20.9 million for FY2025, 46.39% up from the prior year.
- Enterprise Value hit -$20.9 million in Q4 2025 for CervoMed, up from -$27.3 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$6.4 million in Q1 2024 to a low of -$46.5 million in Q3 2024.
- Historically, Enterprise Value has averaged -$25.5 million across 4 years, with a median of -$26.6 million in 2022.
- Biggest five-year swings in Enterprise Value: skyrocketed 63.89% in 2024 and later plummeted 453.36% in 2025.
- Year by year, Enterprise Value stood at -$16.5 million in 2022, then soared by 52.78% to -$7.8 million in 2023, then plummeted by 399.46% to -$38.9 million in 2024, then soared by 46.39% to -$20.9 million in 2025.
- Business Quant data shows Enterprise Value for CRVO at -$20.9 million in Q4 2025, -$27.3 million in Q3 2025, and -$33.5 million in Q2 2025.